Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.

[1]  Smadar Cohen,et al.  Microparticulate Systems for the Delivery of Proteins and Vaccines , 2020 .

[2]  M. Pinto,et al.  Validation of a spectrophotometric method for quantification of xanthone in biodegradable nanoparticles. , 2004, Die Pharmazie.

[3]  M. Pinto,et al.  A validated HPLC method for the assay of xanthone and 3-methoxyxanthone in PLGA nanocapsules. , 2003, Journal of chromatographic science.

[4]  E. Sousa,et al.  Inhibition of α, βI, δ, η and ζ Protein Kinase C Isoforms by Xanthonolignoids , 2003, Journal of enzyme inhibition and medicinal chemistry.

[5]  M. E. Sousa,et al.  Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. , 2002, Bioorganic & medicinal chemistry.

[6]  S. Simões,et al.  Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[7]  E. Sousa,et al.  Synthesis and in vivo modulatory activity of protein kinase C of xanthone derivatives. , 2002, Bioorganic & medicinal chemistry.

[8]  F. Vrečer,et al.  Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. , 2002, International journal of pharmaceutics.

[9]  N. Santos-Magalhães,et al.  Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules. , 2000, International journal of pharmaceutics.

[10]  P. Legrand,et al.  Poly(D,L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. , 2000, Journal of pharmaceutical sciences.

[11]  H. Cidade,et al.  Immunomodulatory Activity of Xanthones from Calophyllum teysmannii var. inuphylloide , 1999, Planta medica.

[12]  M. Morishita,et al.  Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. , 1999, Drug development and industrial pharmacy.

[13]  S. Davis,et al.  PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[14]  C. Rhodes,et al.  Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches. , 1998, Drug development and industrial pharmacy.

[15]  E. Fernandes,et al.  1H and 13C NMR Spectroscopy of mono‐, di‐, tri‐ and tetrasubstituted xanthones , 1998 .

[16]  P. Maincent,et al.  Polymeric Dispersions as Drug Carriers , 1998 .

[17]  María J. Alonso,et al.  Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .

[18]  J. Atkinson,et al.  The antihypertensive effect of orally administered nifedipine‐loaded nanoparticles in spontaneously hypertensive rats , 1997, British journal of pharmacology.

[19]  Chun-nan Lin,et al.  Synthesis and Anti‐inflammatory Effects of Xanthone Derivatives , 1996, The Journal of pharmacy and pharmacology.

[20]  M. Alonso,et al.  Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. , 1996, Journal of pharmaceutical sciences.

[21]  F. Carvalho,et al.  Hepatoprotective Activity of Xanthones and Xanthonolignoids Against tert-Butylhydroperoxide-Induced Toxicity in Isolated Rat Hepatocytes—Comparison with Silybin , 1995, Pharmaceutical Research.

[22]  H. Fessi,et al.  Poly (DL-lactide) nanocapsules containing diclofenac: I. Formulation and stability study , 1995 .

[23]  P. Lowe,et al.  Calcitonin and Insulin in Isobutylcyanoacrylate Nanocapsules: Protection Against Proteases and Effect on Intestinal Absorption in Rats , 1994, The Journal of pharmacy and pharmacology.

[24]  C. Morin,et al.  Improved intracellular delivery of a muramyl dipeptide analog by means of nanocapsules. , 1994, International journal of immunopharmacology.

[25]  H. Fessi,et al.  Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. , 1994, International journal of immunopharmacology.

[26]  M. Alonso,et al.  Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A , 1993 .

[27]  P. Couvreur,et al.  Intracellular targeting of antibiotics by means of biodegradable nanoparticles , 1992 .

[28]  S. Benita,et al.  Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model , 1990 .

[29]  H. Fessi,et al.  In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules. , 1990, Journal of pharmaceutical sciences.

[30]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[31]  Gilbert S. Banker,et al.  Pharmaceutical Dosage Forms: Disperse Systems , 1988 .

[32]  V. Bhalla,et al.  inhibition in , 2005 .

[33]  Francisco Orallo,et al.  Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol , 2004, Pharmaceutical Research.

[34]  M. Pinto,et al.  Natural and synthetic xanthonolignoids: chemistry and biological activities. , 2003, Current medicinal chemistry.

[35]  Scheila Rezende Schaffazick,et al.  Caracterização e estudo de estabilidade de suspensões de nanocápsulas e de nanoesferas poliméricas contendo diclofenaco , 2002 .

[36]  T. Nagem,et al.  Tetraoxygenated naturally occurring xanthones. , 2000, Phytochemistry.

[37]  P. Legrand,et al.  Polymeric nanocapsules as drug delivery systems. A review , 1999 .

[38]  C. Chabenat,et al.  Primidone-loaded poly-epsilon-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles. , 1999, International journal of pharmaceutics.

[39]  J. Irache,et al.  Entrapment efficiency and initial release of phenylbutazone from nanocapsules prepared from different polyesters. , 1998, Drug development and industrial pharmacy.

[40]  M. Alonso.  Nanoparticulate Drug Carrier Technology , 1996 .

[41]  G. Cavallaro,et al.  Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs. , 1996, Biomaterials.

[42]  Pilar Calvo Salde.  Desarrollo de nuevos sistemas coloidales y su aplicación en la administración tópica ocular de medicamentos , 1995 .

[43]  Patrick Couvreur,et al.  Controlled drug delivery with nanoparticles : current possibilities and future trends , 1995 .

[44]  S. Benita,et al.  Nanoparticle characterization : a comprehensive physicochemical approach , 1991 .